CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) today announced that the Company will host an Investor Day on Thursday, December 10, 2015 from 12:00 p.m. to 5:00 p.m. Eastern Standard Time in New York City.
Alexion’s leadership team will highlight the continued advancement of the Company’s highly innovative early and late-stage pipeline which is focused on serving patients with devastating and rare diseases. The company will also provide updates on key aspects of its long-term growth strategy for its complement and metabolic franchises.
